EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Progress of Pancreatectomy for Pancreatic Cancer Treatment—Lessons Learned and Future Challenges

Reinhold Függer iD, Matthias Biebl iD

Cancers · 16.07.2026 · 18 (14) · 2297

DOI: 10.3390/cancers18142297 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 16.07.2026. Verfasst von Reinhold Függer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of General, Visceral, Thoracic and Transplant Surgery, Ordensklinikum Linz, 4020 Linz, Austria. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since decades, surgery of pancreatic adenocarcinoma is confronted with two major challenges. First, the prognosis of pancreatic adenocarcinoma is the worst of all gastrointestinal malignancies, characterized by late diagnosis and aggressive tumor biology. Second, postoperative mortality and morbidity have been exceptionally high, giving pancreatic resection a reputation of being one of the most dangerous procedures. This narrative review concentrates on the progress in decreasing postoperative mortality by centralization and standardization, the exertion of extended resections for local tumor clearance and multimodal strategies to improve oncologic survival. Research regarding surgical techniques, especially robotic assistance, indicated further progress in minimizing the perioperative trauma. Multimodal treatment concepts have been implemented with adjuvant therapy in resectable and neoadjuvant regimen in borderline and locally advanced cancer. However, significant problems have to be solved. Postoperative morbidity remains high, hindering the administration of adjuvant therapy, and toxicity is an essential factor in neoadjuvant strategies. Despite neoadjuvant therapies, resection rates of locally advanced carcinoma are modest and tumor progression hinders resection of borderline and resectable carcinomas. Obviously, deficits in understanding tumor biology are a central obstacle in improving resection rates and overall survival. Hence, improvement in selection of patients for surgical resection apart from using preoperative anatomical findings is mandatory. The progression of current standards, future developments and the status of surgery in multimodal concepts to treat pancreatic adenocarcinoma are delineated using historical and recent reports, registry data, meta-analysis and randomized controlled trials.

Schlagwörter

Stichwörter der Autor:innen

mortality and morbiditymultimodal therapypancreatic ductal adenocarcinomapancreatic resectionresectabilitytumor biology

Autor:innen und Institutionen

  • Department of General, Visceral, Thoracic and Transplant Surgery, Ordensklinikum Linz, 4020 Linz, Austria.
  • Faculty of Medicine, Johannes Kepler University, 4040 Linz, Austria.

ORCID-Profile: Reinhold Függer, Matthias Biebl

Zitieren

APA

Függer, R., & Biebl, M. (2026). The Progress of Pancreatectomy for Pancreatic Cancer Treatment—Lessons Learned and Future Challenges. Cancers, 18(14), 2297. https://doi.org/10.3390/cancers18142297

Vancouver

Függer R, Biebl M. The Progress of Pancreatectomy for Pancreatic Cancer Treatment—Lessons Learned and Future Challenges. Cancers. 2026;18(14):2297. doi:10.3390/cancers18142297

BibTeX
@article{Fgger2026,
  author = {Függer, Reinhold and Biebl, Matthias},
  title = {The Progress of Pancreatectomy for Pancreatic Cancer Treatment—Lessons Learned and Future Challenges},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {14},
  pages = {2297},
  doi = {10.3390/cancers18142297}
}
Kostenlos starten →